Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 582 of 5804
-
Smartphone app aims to help black smokers with HIV kick the habit
Disease control CompletedThe present investigation aims to address disparities in cigarette use outcomes among Black/African American adults with HIV. The specific aims of this study are: (1) To modify a recently developed, culturally adapted, mobile application for Black smokers by integrating informati…
Phase: NA • Sponsor: University of Houston • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a single gene shot replace monthly eye injections for wet AMD?
Disease control OngoingVAN-2201 is Phase I clinical trial to assess the safety and tolerability of KH631 in subjects with neovascular AMD. KH631 is gene therapy designed to deliver a protein which targets and blocks VEGF via an adeno-associated viral vector. The standard of care for patients with neova…
Phase: PHASE1 • Sponsor: Chengdu Origen Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could a simple sponge replace endoscopy for esophageal cancer screening?
Diagnosis Recruiting nowThis clinical trial evaluates the use of cytosponge, a minimally invasive collection device, for the detection of Barrett's esophagus (BE) in patients undergoing endoscopy. Non-endoscopic swallowable encapsulate sponge cell collection devices combined with markers for BE/esophage…
Phase: NA • Sponsor: Mayo Clinic • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
New drug duo takes on advanced cancers in early trial
Disease control OngoingA Phase Ib/II Open-label Clinical Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of AK127 in combination with AK112 in Patients with Advanced Malignant Tumors
Phase: PHASE1, PHASE2 • Sponsor: Akeso • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New asthma drug shows promise in reducing attacks
Disease control CompletedThis is a Phase 2b, global, multicenter, randomized, double-blind, placebo-controlled, parallel group, dose ranging study to assess the efficacy, safety, and tolerability of add-on therapy with SC lunsekimig in adult participants aged 18 to 80 years, (inclusive) with moderate-to-…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New shot could help shed pounds – early trial underway
Disease control CompletedTo assess the efficacy of HRS9531 injection compared with placebo in weight reduction in overweight or obese subjects after 36 weeks of treatment.
Phase: PHASE2 • Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Hope for women with chronic cystitis: raphamin trial aims to stop recurring UTIs
Prevention OngoingClinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial Cystitis
Phase: PHASE3 • Sponsor: Materia Medica Holding • Aim: Prevention
Last updated Jun 27, 2026 09:04 UTC
-
Virtual support may shield latina moms from postpartum depression
Prevention Recruiting nowPostpartum depression (PPD) affects 10-20% of women, with immigrant Latinas disproportionately affected. PPD prevention and treatment is limited among immigrant Latinas due to an array of structural and cultural factors, suggesting the need to deliver interventions outside of tra…
Phase: NA • Sponsor: Northwestern University • Aim: Prevention
Last updated Jun 27, 2026 12:05 UTC
-
Could a parasite drug boost cancer immunotherapy? new trial investigates
Disease control Recruiting nowThis phase II trial studies the side effects and best dose of ivermectin in combination with balstilimab or pembrolizumab and to see how well they they work in shrinking tumors in patients with triple negative breast cancer that has spread to other places in the body (metastatic)…
Phase: PHASE1, PHASE2 • Sponsor: Yuan Yuan • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New drug aims to shrink Hard-to-Treat lung cancers
Disease control Recruiting nowThis study is open to adults with small cell lung cancer and other neuroendocrine tumours. The study is in people with advanced cancer for whom previous treatment was not successful or no standard treatment exists. The purpose of this study is to find a suitable dose of BI 76453…
Phase: PHASE2 • Sponsor: Boehringer Ingelheim • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New hope for liver cancer patients with damaged livers?
Disease control CompletedLiver cancer is the third leading cause of cancer-related deaths worldwide. The majority of primary liver cancers occur as hepatocellular carcinoma (HCC), the incidence of which is increasing in many parts of the world. The vast majority of HCC cases occur in the setting of liver…
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New hope for frail myeloma patients: phase III trial tests smarter drug combos
Disease control Recruiting nowThis phase III trial compares three-drug induction regimens followed by double-or single-drug maintenance therapy for the treatment of newly diagnosed multiple myeloma in patients who are not receiving a stem cell transplant and are considered frail or intermediate-fit based on a…
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New pill could help psoriasis on scalp, genitals, and palms
Disease control OngoingThe purpose of the study is to see how effective JNJ-77242113 is in participants with plaque psoriasis affecting special areas (scalp, genital, and/or palms of the hands and the soles of the feet).
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New pill could clear psoriasis in major trial
Disease control OngoingThe purpose of this study is see how effective is JNJ-77242113 in participants with moderate to severe plaque psoriasis.
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New hope for migraine sufferers: dysport shots aim to cut headache days
Disease control OngoingThe purpose of this study is to understand the safety and effectiveness of the study drug, Dysport® when compared with placebo in preventing chronic migraine. A migraine is a headache with severe throbbing pain or a pulsating sensation, usually on one side of the head, and is of…
Phase: PHASE3 • Sponsor: Ipsen • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Antioxidant pill shows promise in slowing blindness
Disease control OngoingRetinitis pigmentosa (RP) is an inherited retinal degeneration caused by one of several mistakes in the genetic code. Such mistakes are called mutations. The mutations cause degeneration of rod photoreceptors which are responsible for vision in dim illumination resulting in night…
Phase: PHASE3 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Engineered immune cells target Hard-to-Treat cancers in new trial
Disease control TerminatedTo find the recommended dose of TROP2- CAR-NK given intraperitoneally (directly into the abdominal cavity) to patients with highgrade serous ovarian cancer that has not responded to previous treatment or is resistant to treatment.
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can a diet and coaching program reverse type 2 diabetes in memphis?
Disease control CompletedThe HEAL Diabetes Program is a multicomponent intensive plant-forward healthy eating program designed to reverse diabetes. Several recent studies, most notably the Diabetes UK-funded Diabetes Remission Clinical Trial (DiRECT) in England and Scotland, have demonstrated that intens…
Phase: NA • Sponsor: University of Tennessee • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Could a gentler ICU environment boost brain development in heart babies?
Disease control OngoingThe proposed study includes a newborn developmental intervention to improve neurodevelopmental (ND) and medical outcomes for infants with congenital heart disease (CHD) with improved parent well-being. Literature documents long-term ND disabilities for children with CHD, caused b…
Phase: NA • Sponsor: Boston Children's Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New heart preservation method could expand donor pool for transplants
Disease control OngoingThe purpose of this study is to evaluate if Non-Ischemic Heart Preservation (NIHP) of extended criteria donor hearts using the XVIVO Heart Preservation System (XHPS) is a safe and effective way to preserve and transport hearts for transplantation.
Phase: NA • Sponsor: XVIVO Perfusion • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC